Fabry Disease: Percutaneous Transluminal Septal Myocardial Ablation Markedly Improved Symptomatic Left Ventricular Hypertrophy and Outflow Tract Obstruction in a Classically Affected Male
- 11 April 2005
- journal article
- case report
- Published by Wiley in Echocardiography
- Vol. 22 (4) , 333-339
Abstract
Fabry disease (α‐galactosidase A deficiency) is an X‐linked recessive lysosomal storage disease in which left ventricular hypertrophy (LVH) is common, and if severe, may mimic hypertrophic obstructive cardiomyopathy. Alcohol‐induced percutaneous transluminal septal myocardial ablation (PTSMA) has been used as a safe and effective method to alleviate LVH obstruction in patients with hypertrophic obstructive cardiomyopathy (HCM). We describe a case of a classically affected Fabry 53‐year‐old male with symptomatic HCM (NYHA class III with exertional angina) who was treated with PTSMA. The procedure safely and effectively alleviated symptomatic left ventricular outflow tract obstruction at long‐term follow‐up, and the patient's NYHA classification was reduced to NYHA class I to II.Keywords
This publication has 24 references indexed in Scilit:
- Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry DiseaseThe American Journal of Human Genetics, 2004
- Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry DiseaseCirculation, 2003
- PR Interval and the Response to Enzyme-Replacement Therapy for Fabry's DiseaseNew England Journal of Medicine, 2003
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001
- A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety StudiesThe American Journal of Human Genetics, 2001
- Fabry Disease: Preclinical Studies Demonstrate the Effectiveness of α-Galactosidase A Replacement in Enzyme-Deficient MiceThe American Journal of Human Genetics, 2001
- Fabry Disease (α-Galactosidase A Deficiency)2001
- Echocardiographic abnormalities and disease severity in Fabry's diseaseJACC, 1986
- Electrocardiographic and vectorcardiographic abnormalities in Fabry's diseaseAmerican Heart Journal, 1977
- Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies.Circulation, 1976